Faisal Sobia, Mirza Faryal Sardar
AACE Clin Case Rep. 2020 Sep 24;6(6):e342-e345. doi: 10.4158/ACCR-2020-0282. eCollection 2020 Nov-Dec.
Vitamin D deficiency is prevalent worldwide and is usually treated with oral supplementation. Bioavailability of vitamin D may differ among individuals due to variable absorption and metabolism in the body.
A 66-year-old woman presented for evaluation of low 25-hydroxyvitamin D (25[OH]D) level. She had no known prior history of gastric or intestinal surgeries or malabsorptive conditions. She had previously been treated with oral vitamin D at 2,000 IU daily with poor response. She was then treated with oral vitamin D at 50,000 IU weekly, with persistently low 25(OH)D level at 14 ng/mL after 8 weeks of treatment.
Celiac screen was negative and duodenal biopsy was normal. Due to demonstration of poor oral absorption, she was prescribed vitamin D at 50,000 IU sublingually for 8 weeks and then changed to over-the-counter vitamin D drops sublingually (1,000 IU/drop) at 4,000 IU twice daily due to suboptimal response with vitamin D. 25(OH)D level improved gradually to 28 ng/mL after 12 weeks on this regimen and was at 37 ng/mL at 1 year.
Sublingual vitamin D may be an effective alternative mode of vitamin D supplementation in patients who demonstrate poor oral vitamin D absorption despite adequate supplementation for various reasons.
维生素D缺乏在全球普遍存在,通常采用口服补充剂进行治疗。由于人体吸收和代谢的差异,维生素D的生物利用度在个体间可能有所不同。
一名66岁女性因25-羟维生素D(25[OH]D)水平低前来评估。她既往无已知的胃或肠道手术史或吸收不良情况。她此前每日口服2000国际单位维生素D治疗,效果不佳。随后她每周口服50000国际单位维生素D,治疗8周后25(OH)D水平仍持续低至14纳克/毫升。
乳糜泻筛查为阴性,十二指肠活检正常。由于显示出口服吸收不良,她被处方舌下含服50000国际单位维生素D,持续8周,之后因维生素D反应欠佳,改为每日两次舌下含服非处方维生素D滴剂(每滴1000国际单位),每次4000国际单位。在此治疗方案下,12周后25(OH)D水平逐渐升至28纳克/毫升,1年后为37纳克/毫升。
对于因各种原因尽管补充充足但仍存在口服维生素D吸收不良的患者,舌下含服维生素D可能是一种有效的维生素D补充替代方式。